NEW YORK - The pharmacy benefit management business is under attack. And these middlemen of the arcane United States drug-pricing system are preparing their defenses. PBM giant CVS Health Corp. released a report last week pushing back on accusations that the company and its peers reap excessive profits as they negotiate drug prices on behalf of clients…
Want More Free?
To access 2 more articles, please log in or register for free.
Registered users get access to a limited number of free articles every month.